“BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2” (2026) Magna Neurologica, 4(2), pp. 175–186. doi:10.20961/magnaneurologica.v4i2.3308.